Association between periodontal disease and inflammatory arthritis reveals modulatory functions by melanocortin receptor type 3

American Journal of Pathology

Volumn 184, Issue 8, 2014, Pages 2333-2341

  Montero Melendez, Trinidad ^a   Madeira, Mila F M ^b   Norling, Lucy V ^a   Alsam, Asil ^a   Curtis, Michael A ^a   Da Silva, Tarcília A ^b   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; DEXAMETHASONE; DTRP PEPTIDE; ELCATONIN; MELANOCORTIN 3 RECEPTOR; UNCLASSIFIED DRUG;

AGING; ALVEOLAR BONE LOSS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE INJURY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE MODEL; DISEASE SEVERITY; EXPERIMENTAL ARTHRITIS; HISTOPATHOLOGY; INFANT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; RHEUMATOID ARTHRITIS; SERUM; WILD TYPE; ANIMAL; C57BL MOUSE; COMPLICATION; KNOCKOUT MOUSE; METABOLISM; PERIODONTAL DISEASE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERIODONTAL DISEASES; RECEPTOR, MELANOCORTIN, TYPE 3;

EID: 84904747763     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.04.009     Document Type: Article

References (48)

1. I.B. McInnes, and G. Schett The pathogenesis of rheumatoid arthritis N Engl J Med 365 2011 2205 2219
2. M.C. Boissier, L. Semerano, S. Challal, N. Saidenberg-Kermanac'h, and G. Falgarone Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction J Autoimmun 39 2012 222 228
3. P.C. Taylor Developing anti-TNF and biologic agents Rheumatology (Oxford) 50 2011 1351 1353
4. I. Gantz, and T.M. Fong The melanocortin system Am J Physiol Endocrinol Metab 284 2003 E468 E474
5. A. Catania, C. Lonati, A. Sordi, A. Carlin, P. Leonardi, and S. Gatti The melanocortin system in control of inflammation ScientificWorldJournal 10 2010 1840 1853
6. A.B. Gutman, and T.F. Yu Effects of adrenocorticotropic hormone (ACTH) in gout Am J Med 9 1950 24 30
7. B.N. Cronstein, and R. Terkeltaub The inflammatory process of gout and its treatment Arthritis Res Ther 8 Suppl 1 2006 S3
8. S.J. Getting, H.C. Christian, R.J. Flower, and M. Perretti Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis Arthritis Rheum 46 2002 2765 2775
9. S.J. Getting, L. Gibbs, A.J. Clark, R.J. Flower, and M. Perretti POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation J Immunol 162 1999 7446 7453
10. R. Gong The renaissance of corticotropin therapy in proteinuric nephropathies Nat Rev Nephrol 8 2012 122 128
11. R. Berkovich Treatment of acute relapses in multiple sclerosis Neurotherapeutics 10 2013 97 105
12. L.M. Dumont, C.S. Wu, M.A. Tatnell, J. Cornish, and K.G. Mountjoy Evidence for direct actions of melanocortin peptides on bone metabolism Peptides 26 2005 1929 1935
13. J. Cornish, K.E. Callon, K.G. Mountjoy, U. Bava, J.M. Lin, D.E. Myers, D. Naot, and I.R. Reid α-Melanocyte-stimulating hormone is a novel regulator of bone Am J Physiol Endocrinol Metab 284 2003 E1181 E1190
14. S. Grassel, A. Opolka, S. Anders, R.H. Straub, J. Grifka, T.A. Luger, and M. Bohm The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components Arthritis Rheum 60 2009 3017 3027
15. J.F. Evans, Q.T. Niu, J.A. Canas, C.L. Shen, J.F. Aloia, and J.K. Yeh ACTH enhances chondrogenesis in multipotential progenitor cells and matrix production in chondrocytes Bone 35 2004 96 107
16. M. Bohm, M. Raghunath, C. Sunderkotter, M. Schiller, S. Stander, T. Brzoska, T. Cauvet, H.B. Schioth, T. Schwarz, and T.A. Luger Collagen metabolism is a novel target of the neuropeptide alpha-melanocyte-stimulating hormone J Biol Chem 279 2004 6959 6966
17. M. Bohm, and T.A. Luger Melanocortins in fibroblast biology: current update and future perspective for dermatology Exp Dermatol 13 Suppl 4 2004 16 21
18. H.B. Patel, M. Bombardieri, A.L. Sampaio, F. D'Acquisto, M. Gray, P. Grieco, S.J. Getting, C. Pitzalis, and M. Perretti Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis FASEB J 24 2010 4835 4843
19. S.J. Getting, C.W. Lam, A.S. Chen, P. Grieco, and M. Perretti Melanocortin 3 receptors control crystal-induced inflammation FASEB J 20 2006 2234 2241
20. T. Montero-Melendez, H.B. Patel, M. Seed, S. Nielsen, T.E. Jonassen, and M. Perretti The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties Am J Pathol 179 2011 259 269
21. A.B. Gomez-SanMiguel, A.I. Martin, M.P. Nieto-Bona, C. Fernadez-Galaz, M. Lopez-Menduina, M.A. Villanua, and A. Lopez-Calderon Systemic alpha melanocyte stimulating hormone administration decreases arthritis-induced anorexia and muscle wasting Am J Physiol Regul Integr Comp Physiol 304 2013 R877 R886
22. J.U. Scher, and S.B. Abramson Periodontal disease, Porphyromonas gingivalis, and rheumatoid arthritis: what triggers autoimmunity and clinical disease? Arthritis Res Ther 15 2013 122
23. J.U. Scher, C. Ubeda, M. Equinda, R. Khanin, Y. Buischi, A. Viale, L. Lipuma, M. Attur, M.H. Pillinger, G. Weissmann, D.R. Littman, E.G. Pamer, W.A. Bretz, and S.B. Abramson Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis Arthritis Rheum 64 2012 3083 3094
24. C.M. Queiroz-Junior, M.F. Madeira, F.M. Coelho, V.V. Costa, R.L. Bessoni, L.F. Sousa, G.P. Garlet, G. Souza Dda, M.M. Teixeira, and T.A. Silva Experimental arthritis triggers periodontal disease in mice: involvement of TNF-α and the oral Microbiota J Immunol 187 2011 3821 3830
25. J.C. Park, C. Su, I.H. Jung, S.H. Choi, K.S. Cho, C.K. Kim, Y.B. Park, S.K. Lee, and C.S. Kim Mechanism of alveolar bone loss in a collagen-induced arthritis model in mice J Clin Periodontol 38 2011 122 130
26. C.M. Queiroz-Junior, M.F. Madeira, F.M. Coelho, C.R. de Oliveira, L.C. Candido, G.P. Garlet, M.M. Teixeira, G. de Souza Dda, and T.A. Silva Experimental arthritis exacerbates Aggregatibacter actinomycetemcomitans-induced periodontitis in mice J Clin Periodontol 39 2012 608 616
27. P.A. Monach, D. Mathis, and C. Benoist The K/BxN arthritis model Curr Protoc Immunol Chapter 15 2008 Unit 15.22
28. H.J. Ditzel The K/BxN mouse: a model of human inflammatory arthritis Trends Mol Med 10 2004 40 45
29. D.M. Lee, D.S. Friend, M.F. Gurish, C. Benoist, D. Mathis, and M.B. Brenner Mast cells: a cellular link between autoantibodies and inflammatory arthritis Science 297 2002 1689 1692
30. H.B. Patel, K.N. Kornerup, A.L. Sampaio, F. D'Acquisto, M.P. Seed, A.P. Girol, M. Gray, C. Pitzalis, S.M. Oliani, and M. Perretti The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis Ann Rheum Dis 71 2012 1872 1880
31. A. Al-Kashi, T. Montero-Melendez, N. Moradi-Bidhendi, J.P. Gilligan, N. Mehta, and M. Perretti The calcitonin and glucocorticoids combination: mechanistic insights into their class-effect synergy in experimental arthritis PLoS One 8 2013 e54299
32. M.F. Madeira, C.M. Queiroz-Junior, G.M. Costa, P.C. Santos, E.M. Silveira, G.P. Garlet, P.S. Cisalpino, M.M. Teixeira, T.A. Silva, and G. Souza Dda MIF induces osteoclast differentiation and contributes to progression of periodontal disease in mice Microbes Infect 14 2012 198 206
33. S. Liang, K.B. Hosur, H. Domon, and G. Hajishengallis Periodontal inflammation and bone loss in aged mice J Periodontal Res 45 2010 574 578
34. E.G. Rivaldo, D.P. Padilha, and F.N. Hugo Alveolar bone loss and aging: a model for the study in mice J Periodontol 76 2005 1966 1971
35. D. Khanna, P.P. Khanna, J.D. Fitzgerald, M.K. Singh, S. Bae, T. Neogi, M.H. Pillinger, J. Merill, S. Lee, S. Prakash, M. Kaldas, M. Gogia, F. Perez-Ruiz, W. Taylor, F. Liote, H. Choi, J.A. Singh, N. Dalbeth, S. Kaplan, V. Niyyar, D. Jones, S.A. Yarows, B. Roessler, G. Kerr, C. King, G. Levy, D.E. Furst, N.L. Edwards, B. Mandell, H.R. Schumacher, M. Robbins, N. Wenger, and R. Terkeltaub 2012 American College of Rheumatology guidelines for management of gout, part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis Arthritis Care Res (Hoboken) 64 2012 1447 1461
36. P.S. Hench Introduction: cortisone and ACTH in clinical medicine Proc Staff Meet Mayo Clin 25 1950 474 476
37. C.H. Slocumb, H.F. Polley, P.S. Hench, and E.C. Kendall Effects of cortisone and ACTH on patients with rheumatoid arthritis Proc Staff Meet Mayo Clin 25 1950 476 478
38. D. Axelrod, and S. Preston Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout Arthritis Rheum 31 1988 803 805
39. D. Daoussis, I. Antonopoulos, G. Yiannopoulos, and A.P. Andonopoulos ACTH as first line treatment for acute gout in 181 hospitalized patients Joint Bone Spine 80 2013 291 294
40. J. Ritter, L.D. Kerr, J. Valeriano-Marcet, and H. Spiera ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems J Rheumatol 21 1994 696 699
41. G. Leoni, H.B. Patel, A.L. Sampaio, F.N. Gavins, J.F. Murray, P. Grieco, S.J. Getting, and M. Perretti Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion FASEB J 22 2008 4228 4238
42. I.R. Reid Steroid-induced osteoporosis Osteoporos Int 7 Suppl 3 1997 S213 S216
43. L. Mancini, M.J. Paul-Clark, G. Rosignoli, R. Hannon, J.E. Martin, I. Macintyre, and M. Perretti Calcitonin and prednisolone display antagonistic actions on bone and have synergistic effects in experimental arthritis Am J Pathol 170 2007 1018 1027
44. M.A. Karsdal, K. Henriksen, M. Arnold, and C. Christiansen Calcitonin: a drug of the past or for the future? physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality BioDrugs 22 2008 137 144
45. B.J. Renquist, J.G. Murphy, E.A. Larson, D. Olsen, R.F. Klein, K.L. Ellacott, and R.D. Cone Melanocortin-3 receptor regulates the normal fasting response Proc Natl Acad Sci U S A 109 2012 E1489 E1498
46. A.S. Chen, D.J. Marsh, M.E. Trumbauer, E.G. Frazier, X.M. Guan, H. Yu, C.I. Rosenblum, A. Vongs, Y. Feng, L. Cao, J.M. Metzger, A.M. Strack, R.E. Camacho, T.N. Mellin, C.N. Nunes, W. Min, J. Fisher, S. Gopal-Truter, D.E. MacIntyre, H.Y. Chen, and L.H. Van der Ploeg Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass Nat Genet 26 2000 97 102
47. A.A. Butler, R.A. Kesterson, K. Khong, M.J. Cullen, M.A. Pelleymounter, J. Dekoning, M. Baetscher, and R.D. Cone A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse Endocrinology 141 2000 3518 3521
48. P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, and J.I. Gordon An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 2006 1027 1031